Postpartum hypertension (high blood pressure in the first 42 days after delivery) is the leading reason for readmission to the hospital after a delivery stay. Current guidelines recommend starting medicines to lower blood pressure when a woman’s postpartum measurements are 150/100mmHg or higher on at least 2 occasions at least 4 hours apart in the first 4 days following delivery. However, these recommendations are largely based on expert opinion. In this study, researchers asked how well the blood pressure cutoff of 150/100mmHg can predict a patient needing to be readmitted for high blood pressure problems postpartum. The researchers analyzed a dataset of nearly 25,000 women and found that a blood pressure cutoff of measurements 140/90mmHg or higher was the most reliable predictor of postpartum readmissions for high blood pressure problems. Next steps should be to conduct more studies to test these new blood pressure cutoffs and determine if starting blood pressure lowering medicines at lower blood pressures can in fact help postpartum women avoid being readmitted to the hospital.
LINK: https://pubmed.ncbi.nlm.nih.gov/33451628/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials Finding strategies for preventing preeclampsia is a top priority in...
Masked Pregnancy-Associated Hypertension as a Predictor of Adverse Outcomes Pregnant women who have risk factors for preeclampsia may be advised by their health care provider to monitor their...
Preeclampsia Prevention by Timed Birth at Term In this study, researchers looked at different ways to find out if a pregnant woman might get preeclampsia at term (>37 weeks) and when would be...
Polygenic prediction of preeclampsia and gestational hypertension All humans have near-identical DNA sequences across the estimated 6 billion-letter code that makes up the human genome. However, slig...
Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Messenger ribonucleic acid (mRNA) is a molecule that contains the instructions to tell cells how to make proteins. mRNA is m...